Azenta (AZTA) reported late Tuesday fiscal Q4 adjusted earnings of $0.18 per diluted share, up from $0.13 a year earlier.
Analysts polled by Capital IQ expected $0.11.
Revenue for the quarter ended Sept. 30 was $170.1 million, down from $172.4 million a year earlier.
Analysts polled by Capital IQ expected $169.8 million.
The company expects fiscal 2025 organic revenue from continuing operations, excluding B Medical Systems, to grow 3% to 5% from fiscal 2024.
Azenta is pursuing a sale of the B Medical Systems segment, a manufacturer and distributor of medical refrigeration devices, to simplify the company's portfolio, it said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.